Stock Events

Stock Events

Helix Biomedix 

$6.02
3
+$0.00+0%Friday 20:00

Statistics

Day High
6.02
Day Low
6.02
52W High
6.5
52W Low
1
Volume
100
Avg. Volume
126
Mkt Cap
1.36M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Sep 30Expected
Q4 2010
Q1 2011
Q2 2011
Q3 2011
Q4 2011
Q1 2012
Q2 2012
-4.74
-3.16
-1.58
0
Expected EPS
0
Actual EPS
-4.7376

Financials

-68.4%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
807,000Revenue
-552,000Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap95.99B
Regeneron Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of treatments for serious medical conditions, competing in the biopharmaceutical space similar to Helix Biomedix.
AMGEN
AMGN
Mkt Cap251.94B
Amgen Inc. is a biotech firm developing novel therapies in various therapeutic areas, overlapping with Helix Biomedix's focus on innovative biopharmaceutical solutions.
Vertex Pharmaceuticals
VRTX
Mkt Cap141.65B
Vertex Pharmaceuticals Incorporated operates in the biotechnology and pharmaceuticals sector, developing drugs that could potentially compete with Helix Biomedix's product offerings.
Biogen
BIIB
Mkt Cap37.49B
Biogen Inc. specializes in discovering and delivering therapies for neurological and neurodegenerative diseases, competing with Helix Biomedix in the biotech innovation sector.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that develops and markets medicines in areas potentially overlapping with Helix Biomedix's interests.
Incyte
INCY
Mkt Cap24.54B
Incyte Corporation specializes in oncology products but also has a portfolio that could compete with Helix Biomedix in broader biopharmaceutical applications.
Exelixis
EXEL
Mkt Cap16.93B
Exelixis, Inc. is a biotechnology company that develops small molecule therapies for the treatment of cancer, which could intersect with Helix Biomedix's market.
Biomarin Pharmaceutical
BMRN
Mkt Cap11.33B
BioMarin Pharmaceutical Inc. develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions, competing in the same innovative treatment space as Helix Biomedix.

About

Helix BioMedix, Inc. is a biopharmaceutical company, which focuses on drug development for treatment of rare dermatological diseases, such as Xeroderma Pigmentosum. The company was founded in 1988 and is headquartered in Bothell, WA.
Show More
CEO
Robin L. Carmichael
Employees
8
Country
United States
ISIN
US4232875074

Listings

OTC Link
US
HXBM

0 Comments

Share your thoughts

FAQs

What is Helix Biomedix stock price today?▼
The current price of HXBM is $6.02 USD — it has increased by +0% in the past 24 hours. Watch Helix Biomedix stock price performance more closely on the chart.
What is Helix Biomedix stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Helix Biomedix stocks are traded under the ticker HXBM.
Is Helix Biomedix stock price growing?▼
HXBM stock has risen by +82.98% compared to the previous week, the month change is a +82.98% rise, over the last year Helix Biomedix has showed a +72% increase.
What is Helix Biomedix market cap?▼
Today Helix Biomedix has the market capitalization of 1.36M
What were Helix Biomedix earnings last quarter?▼
HXBM earnings for the last quarter are -4.74 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Helix Biomedix revenue for the last year?▼
Helix Biomedix revenue for the last year amounts to 807,000 USD.
What is Helix Biomedix net income for the last year?▼
HXBM net income for the last year is -552,000 USD.
How many employees does Helix Biomedix have?▼
As of November 2, 2026, the company has 8 employees.
In which sector is Helix Biomedix located?▼
Helix Biomedix operates in the Health & Wellness sector.
When did Helix Biomedix complete a stock split?▼
The last stock split for Helix Biomedix was on January 3, 2013 with a ratio of 1:300.
Where is Helix Biomedix headquartered?▼
Helix Biomedix is headquartered in Bothell, United States.